Clinical-Stage Innovations Bellerophon Therapeutics is focused on developing innovative products for cardiopulmonary and cardiac diseases, presenting sales opportunities for solutions targeting these unmet clinical needs.
Recent Expansion Recent hires like the Chief Medical Officer indicate growth and potential partnerships, offering opportunities for collaborations or product integrations within the biotechnology sector.
Public Offering Impact Going public in 2020 signals a stage of growth and visibility, potentially attracting investors seeking biotechnology opportunities and partnerships.
Product Pipeline Focus With three product candidates under the INOpulse platform, there are opportunities for sales initiatives targeting healthcare providers and institutions looking for advanced treatment options.
Competitive Landscape Understanding similar companies like Verrica Pharmaceuticals and Revolution Medicines can direct sales strategies to differentiate and position Bellerophon Therapeutics effectively in the market.
119
$10M$50M
501$50M$100M
1.3K$100M$1B
275$50M$100MBellerophon Therapeutics uses 8 technology products and services including Google Analytics, Shopify, Twitter Emoji (Twemoji), and more. Explore Bellerophon Therapeutics's tech stack below.
| Bellerophon Therapeutics Email Formats | Percentage |
| First.Last@bellerophon.com | 49% |
| FiLast@bellerophon.com | 1% |
| First.Last@bellerophon.com | 49% |
| FiLast@bellerophon.com | 1% |
Biotechnology ResearchNew Jersey, United States11-50 Employees
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Company Overview
Media & News
Funding & FinancialsBellerophon Therapeutics has raised a total of $5M of funding over 6 rounds. Their latest funding round was raised on Mar 06, 2023 in the amount of $5M.
Bellerophon Therapeutics's revenue is in the range of $10M
Funding & FinancialsBellerophon Therapeutics has raised a total of $5M of funding over 6 rounds. Their latest funding round was raised on Mar 06, 2023 in the amount of $5M.
Bellerophon Therapeutics's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com